What is Trilab?
Trilab Health operates as a high-complexity, COLA-accredited, and CLIA-certified diagnostic facility. The company specializes in a comprehensive suite of services, including molecular testing, toxicology, and rapid infectious disease diagnostics. By prioritizing rapid turnaround times—some as efficient as 15 minutes—Trilab serves as a vital partner for healthcare providers and individual patients alike. Their operational focus on harm reduction, particularly regarding substance abuse and opioid-related diagnostics, distinguishes them within the competitive landscape of clinical pathology. The firm's commitment to accessible, reliable, and compassionate diagnostic solutions has established it as a cornerstone of community health support in Chicago.
How much funding has Trilab raised?
Trilab has raised a total of $5.9M across 4 funding rounds:
Debt
$350K
Debt
$553K
Debt
$500K
Debt
$4.5M
Debt (2020): $350K with participation from PPP
Debt (2021): $553K led by PPP
Debt (2024): $500K, investors not publicly disclosed
Debt (2024): $4.5M featuring First Busey
Key Investors in Trilab
First Busey
A diversified financial services institution providing commercial banking and wealth management solutions to support enterprise-level growth.
PPP
Public-Private Partnership
Undisclosed Investors
What's next for Trilab?
With the recent infusion of capital, Trilab is expected to accelerate its operational scaling and technological integration. The company's strategic roadmap likely involves enhancing its molecular testing infrastructure to meet the rising demand for precision medicine and specialized toxicology screening. As the healthcare industry shifts toward more decentralized and rapid diagnostic models, Trilab is well-positioned to capitalize on these trends. Future initiatives will likely focus on expanding its footprint within healthcare facilities, optimizing supply chain efficiencies for reagent procurement, and potentially diversifying its diagnostic portfolio to address emerging public health challenges. This financial milestone provides the necessary runway to sustain long-term innovation and maintain its high standards of clinical excellence.
See full Trilab company page
